Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...

Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...

Weaver outlined her concerns with counterfeit weight-loss medication. “If there is, contaminants, allergens in it, that sort ...

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to ...

A more recent trial using the GLP-1 agonist tirzepatide (Mounjaro or Zepbound) found a 93% reduction in diabetes risk. These studies were done in people whose major risk for diabetes was obesity.

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

In this post-hoc analysis of the SURMOUNT-1 trial, there was a mostly linear relationship between percentage change in weight ...

While Eli Lilly brushed off concerns about gastrointestinal side effects for oral weight loss candidate orforglipron, ...